10-Q: Herbalife Q2 2025: Net Income Soars Amidst Sales Dip

Herbalife Ltd. reported a significant increase in net income for Q2 2025, despite a slight decrease in net sales, driven by lower operating expenses and strategic acquisitions.

Summary

• Net sales decreased by 1.7% to $1,259.1 million for the three months ended June 30, 2025, and by 2.5% to $2,480.8 million for the six months ended June 30, 2025, compared to the same periods in 2024.
• Net income attributable to Herbalife increased by 948.9% to $49.3 million for the three months ended June 30, 2025, and by 243.8% to $99.7 million for the six months ended June 30, 2025, compared to the same periods in 2024.
• Diluted earnings per share (EPS) rose to $0.48 for the three months and $0.97 for the six months ended June 30, 2025, up from $0.05 and $0.29 respectively in 2024.
• The increase in net income was primarily due to $54.4 million lower selling, general, and administrative (SG&A) expenses in Q2 2025 and $114.7 million lower SG&A in H1 2025, driven by reduced labor and benefits costs, including lower employee retention/separation costs and bonus accruals.
• The company completed asset acquisitions of Pruvit and Pro2col LLC for $19 million and a business acquisition of Link BioSciences Inc. for $6.5 million in April 2025, totaling $25.5 million.
• Operating cash flow decreased to $96.2 million for the six months ended June 30, 2025, from $116.3 million in the same period of 2024.
• Total debt outstanding as of June 30, 2025, was $2,141.5 million, down from $2,260.1 million as of December 31, 2024.
• The company expects total capital expenditures of approximately $75 million to $95 million for the full year 2025, including investments in the Herbalife One Digital Technology Program.

Sentiment

Score: 7

Explanation: While net sales declined, the company demonstrated strong profitability improvements driven by effective cost management and strategic acquisitions. Ongoing investments in technology and positive legal outcomes contribute to a favorable outlook, despite persistent macroeconomic headwinds and sales volume challenges.

Positives

• Net income attributable to Herbalife increased significantly by 948.9% for the three months ended June 30, 2025, and 243.8% for the six months ended June 30, 2025.
• Diluted EPS rose to $0.48 for the three months and $0.97 for the six months ended June 30, 2025, demonstrating strong earnings growth.
• Selling, general, and administrative expenses decreased by $54.4 million for the three months and $114.7 million for the six months ended June 30, 2025, primarily due to lower labor and benefits costs, including reduced employee retention/separation costs and bonus accruals.
• Successfully launched the beta version of the new Pro2col health and wellness digital platform in North America in July 2025.
• Maintained compliance with all financial covenants under the 2024 Credit Facility as of June 30, 2025, and December 31, 2024.
• The direct selling license in Vietnam was renewed until January 2030.
• Received favorable verdicts at the Tax Tribunal level for Indian income tax assessments for fiscal years March 31, 2017, and March 31, 2018.
• A lawsuit against a former technology services vendor, Eastern Computer Exchange, Inc., resulted in a verdict in favor of the company, including a $1.5 million judgment on the fraudulent concealment claim.

Negatives

• Net sales decreased by 1.7% for the three months ended June 30, 2025, and 2.5% for the six months ended June 30, 2025.
• Sales volume decreased by 3.1% for the three months and 2.7% for the six months ended June 30, 2025.
• Unfavorable impact of foreign currency exchange rate fluctuations on net sales, contributing to a 1.7% decrease for the three months and 3.2% for the six months ended June 30, 2025.
• Operating cash flow decreased to $96.2 million for the six months ended June 30, 2025, from $116.3 million in the same period of 2024.
• Interest expense, net, increased by $10.0 million for the six months ended June 30, 2025, primarily due to an increase in the weighted-average interest rate from the April 2024 debt refinancing transactions.
• Ongoing macroeconomic conditions, including inflation, high interest rates, and geopolitical conflicts, continue to challenge operations and customer demand in certain markets.
• The Russia entity had no sales during the six months ended June 30, 2025, due to the suspension of product shipments and fully depleted inventory.

Risks

• Potential impacts of current global economic conditions, including inflation, unfavorable foreign exchange rate fluctuations, and tariffs or retaliatory tariffs, on the company, its Members, customers, and supply chain, and the world economy.
• Ability to attract and retain Members.
• Relationship with, and ability to influence the actions of, Members.
• Noncompliance with, or improper action by employees or Members in violation of, applicable U.S. and foreign laws, rules, and regulations.
• Adverse publicity associated with the company or the direct-selling industry, including ability to comfort the marketplace and regulators regarding compliance with applicable laws.
• Changing consumer preferences and demands and evolving industry standards, including with respect to climate change, sustainability, and other environmental, social, and governance matters.
• Competitive nature of the business and industry.
• Legal and regulatory matters, including regulatory actions concerning, or legal challenges to, products or network marketing program and product liability claims.
• The Consent Order entered into with the Federal Trade Commission (FTC), the effects thereof and any failure to comply therewith.
• Risks associated with operating internationally and in China.
• Ability to execute growth and other strategic initiatives (such as restructuring efforts and increased market penetration in existing markets).
• Effectiveness and acceptance of new technology-driven initiatives.
• Any material disruption to the business caused by natural disasters, other catastrophic events, acts of war or terrorism, including the wars in Ukraine and the Middle East, cybersecurity incidents, pandemics, and/or other acts by third parties.
• Ability to adequately source ingredients, packaging materials, and other raw materials and manufacture and distribute products.
• Reliance on information technology infrastructure, and ability to successfully develop, deploy, and integrate artificial intelligence into the business.
• Noncompliance by the company or Members with any privacy laws, rules, or regulations or any security breach involving the misappropriation, loss, or other unauthorized use or disclosure of confidential information.
• Contractual limitations on ability to expand or change the direct-selling business model.
• Sufficiency of trademarks and other intellectual property.
• Product concentration.
• Reliance upon, or the loss or departure of any member of, the senior management team.
• Ability to integrate and capitalize on acquisition transactions, including potential for inaccurate value assessment, failure to realize anticipated benefits, liability for unknown pre-acquisition liabilities, impairment of other acquired assets, significant demands on management time, and post-transaction disputes.
• Restrictions imposed by covenants in the agreements governing indebtedness.
• Risks related to convertible notes.
• Changes in, and uncertainties relating to, the application of transfer pricing, income tax, customs duties, value added taxes, and other tax laws, treaties, and regulations, or their interpretation.
• Incorporation under the laws of the Cayman Islands.
• Share price volatility related to, among other things, speculative trading and certain traders shorting common shares.
• Uncertainty in estimating income taxes and the potential for material impact from changes in valuation allowances.
• Product liability claims.
• Delays in processing VAT refunds in Mexico, with $16.7 million of Mexico VAT-related assets outstanding.
• Tax assessments from the Mexican Tax Administration Service for 2019 VAT of approximately $23.2 million.
• Tax assessments from the Federal Revenue Office of Brazil related to withholding/contributions based on payments to Members, totaling approximately $15.9 million.
• Tax assessments from Brazilian states related to indirect taxes (ICMS and ICMS-ST), including approximately $29.3 million and $10.9 million for 2013 and 2014 tax years in São Paulo, and additional assessments for 2017-2023 totaling approximately $96.3 million.
• Tax assessments in India from VAT and Service Tax authorities of approximately $12.0 million.
• Indian income tax authorities assessments for fiscal years ended March 31, 2017, 2018, 2020, 2021, and 2022, totaling approximately $106.3 million.

Future Outlook

The company expects total capital expenditures of approximately $75 million to $95 million for the full year 2025, including continued investments in the Herbalife One Digital Technology Program. It anticipates recognizing $40 million to $45 million of non-cash amortization expenses for Herbalife One in 2025 and similar amounts thereafter. The first phase of the Technology Realignment Program is expected to deliver annual savings of approximately $9 million beginning in 2026, with about $6 million in savings expected in 2025, and is anticipated to be completed in 2025. The company continues to monitor macroeconomic and geopolitical conditions, acknowledging potential impacts on its business, and intends to continue applying for government grants in China when programs are available, though there is no assurance of future grants.

Management Comments

• "We believe enhanced consumer awareness and demand for our products due to global trends such as the obesity epidemic, increasing interest in a fit and active lifestyle, living healthier, and the rise of entrepreneurship, coupled with the effectiveness of personalized selling through a direct sales channel, have been the primary reasons for our continued success."
• "Management's role, in-country and at the region and corporate level, is to provide Members with a competitive, broad, and innovative product line, offer leading-edge business tools and technology services, and encourage strong teamwork and Member leadership to make doing business with Herbalife simple."
• "We continue to provide our Members with enhanced technology tools, which includes updated brand sites, for ordering, business performance, and customer retailing to make it easier for them to do business with us and to optimize their customers experiences."
• "We continue to examine our cost structure and assess additional potential incremental pricing actions in response to ongoing inflationary pressures and any tariffs and retaliatory tariffs imposed by the U.S. or foreign governments which could have a significant adverse impact to our business."

Industry Context

The company operates within the global nutrition and direct selling industry, which is currently shaped by significant health trends such as the obesity epidemic and a growing consumer interest in active, healthy lifestyles. The direct selling model, characterized by personalized sales and network building, remains central to the company's strategy. The industry, like many others, is navigating a complex global economic environment marked by inflation, fluctuating foreign exchange rates, and geopolitical tensions. The company's focus on digital transformation and new product acquisitions aligns with broader industry efforts to leverage technology for enhanced customer engagement and operational efficiency.

Comparison to Industry Standards

• NA

Legal Proceedings

• Lawsuit: Herbalife International of America, Inc. vs. Eastern Computer Exchange, Inc. (Company won, including a $1.5 million judgment on the fraudulent concealment claim).
• Purported class action lawsuit: Sarah DeSimone v. Herbalife Ltd. et al. (alleging California Labor Code violations, including misclassification of distributors as independent contractors; company will vigorously defend).
• Tax matters in Mexico: Delayed processing of VAT refunds ($16.7 million outstanding) and a $23.2 million tax assessment for the 2019 tax year relating to VAT (company filed administrative appeal).
• Tax assessments from the Federal Revenue Office of Brazil related to withholding/contributions based on payments to Members, with an aggregate combined amount of approximately $15.9 million (company is litigating).
• Tax assessments in Brazil from various states related to indirect taxes (ICMS and ICMS-ST), including approximately $29.3 million and $10.9 million for 2013 and 2014 tax years in São Paulo (company is litigating at Judicial level), and additional assessments for 2017-2023 totaling approximately $96.3 million (under Administrative appeal).
• Tax assessment in Brazil for the State of Rio de Janeiro of approximately $6.4 million relating to ICMS-ST issues for 2016 and 2017 tax years (company is appealing).
• Other ICMS tax assessments in Brazil totaling $2.6 million from several other states.
• Various tax assessments in multiple jurisdictions in India from VAT and Service Tax authorities totaling approximately $12.0 million (company is litigating).
• Indian income tax authorities assessments for fiscal years ended March 31, 2017, 2018, 2020, 2021, and 2022, totaling approximately $17.0 million, $16.5 million, $21.7 million, $19.1 million, and $27.0 million respectively (company intends to litigate).

Stakeholder Impact

• **Shareholders**: Experienced a significant increase in net income and EPS, which is positive, but faced a decline in net sales and sales volume, indicating ongoing challenges. The reduction in shareholders' deficit is a positive sign.
• **Employees**: Affected by the Restructuring Program and Technology Realignment Program, which involved employee retention and separation costs, suggesting workforce adjustments aimed at efficiency.
• **Customers**: Expected to benefit from new product offerings through acquisitions (Pruvit, Link BioSciences) and enhanced digital experiences via the Pro2col platform and Herbalife One initiative.
• **Distributors/Members**: Supported by new technology tools, training, and promotional programs designed to enhance their business operations and customer retailing efforts. However, macroeconomic conditions and sales volume declines in certain regions may impact their business.
• **Creditors**: The company is in compliance with its financial covenants under the 2024 Credit Facility and has made principal payments on its debt, which is favorable for creditors.

Next Steps

• Commercial release of the Pro2col technology platform in the U.S. and Puerto Rico is planned for the fourth quarter of 2025.
• Additional markets for the Pro2col technology platform are expected to follow beginning in 2026.
• The first phase of the Technology Realignment Program is expected to be completed in 2025.
• The company intends to continue applying for government grants in China when programs are available.
• The company will continue to litigate tax assessments in Brazil and India.
• The company continues to analyze the potential full impact of the One Big Beautiful Bill Act (OBBBA) on its consolidated financial statements.

Key Dates

Recommendation

While the company demonstrated strong profitability improvements driven by effective cost efficiencies and strategic acquisitions, the persistent decline in net sales and sales volume across multiple regions remains a significant concern. The macroeconomic headwinds, particularly foreign exchange fluctuations and high interest rates, coupled with ongoing legal and tax contingencies, introduce a layer of uncertainty. The stock is a 'hold' as investors should monitor whether the profitability gains are sustainable and if the new digital initiatives and product launches can effectively reverse the negative sales volume trend. The company's debt structure and interest rate sensitivity also warrant careful consideration.

Keywords

Herbalife, nutrition, direct selling, multi-level marketing, weight management, dietary supplements, financial results, SEC filing, 10-Q, HLF, Q2 2025, earnings, sales, debt, acquisitions, corporate governance, risk factors, global operations